Dianthus Therapeutics, Inc. (DNTH) vs Indivior Pharmaceuticals Inc (INDV)
A side-by-side comparison of Dianthus Therapeutics, Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DNTH
Dianthus Therapeutics, Inc.
$84.33HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
INDV
Indivior Pharmaceuticals Inc
$35.76HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — DNTH vs INDV
growth of $100 · dividends reinvested · last 8yDNTH -62.1% (-11.4%/yr)INDV +48.4% (+5.1%/yr)INDV compounded faster over this window
DNTH INDV
DNTH vs INDV: by the numbers
- •DNTH is the larger company ($4.72B vs $4.46B market cap).
- •INDV is profitable (26.65% net margin) while DNTH runs a net loss (-1570.85%).
- •INDV pays a dividend (1.32% yield), while DNTH has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DNTH | INDV |
|---|---|---|
| P/E ratio | N/A | 12.82 |
| Forward P/E | N/A | 8.47 |
| P/S ratio | 2477.49 | 3.35 |
| P/B ratio | 4.02 | N/A |
| EV / EBITDA | N/A | 8.91 |
Profitability
| Metric | DNTH | INDV |
|---|---|---|
| Gross margin | 96.01% | 83.86% |
| Operating margin | -8739.34% | 21.39% |
| Net margin | -1570.85% | 26.65% |
| ROE | -2.55% | N/A |
| ROIC | -18.48% | N/A |
Dividends
| Metric | DNTH | INDV |
|---|---|---|
| Dividend yield | N/A | 1.32% |
| Payout ratio | N/A | 17.03% |
Growth (annualized)
| Metric | DNTH | INDV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.88% |
| Total return CAGR (5Y) | -5.50% | 19.65% |
Frequently asked
- Does DNTH or INDV pay a bigger dividend?
- INDV pays a dividend (1.32% yield), while DNTH has no payments in the available dividend history.
- Is DNTH or INDV more profitable?
- INDV runs the higher net margin — DNTH at -1570.85% versus INDV at 26.65%.
- How have DNTH and INDV total returns compared?
- Over the past 5 years, DNTH delivered -5.50% and INDV delivered 19.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Indivior Pharmaceuticals P/E ratioIndivior Pharmaceuticals dividend yieldDianthus Therapeutics ROEIndivior Pharmaceuticals ROEDianthus Therapeutics operating marginIndivior Pharmaceuticals operating marginDianthus Therapeutics revenue growthIndivior Pharmaceuticals revenue growthDianthus Therapeutics free cash flowIndivior Pharmaceuticals free cash flow
Dianthus Therapeutics & Indivior Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.